During the last session, Asensus Surgical, Inc. (NYSE:ASXC)’s traded shares were 3,190,000,000, with the beta value of the company hitting 1.83. At the end of the trading day, the stock’s price was $3, reflecting an intraday loss of -4.76% or -$0.15. The 52-week high for the ASXC share is $6.95, that puts it down -131.67% from that peak though still a striking +90% gain since the share price plummeted to a 52-week low of $0.3. The company’s market capitalization is $697.77 Million, and the average intraday trading volume over the past 10 days was 9.74 Million shares, and the average trade volume was 32.46 Million shares over the past three months.
Asensus Surgical, Inc. (ASXC) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3. ASXC has a Sell rating from none of the analyst(s) out of 2 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and no one recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.07.
Asensus Surgical, Inc. (NYSE:ASXC): Trading Information
Asensus Surgical, Inc. (ASXC) registered a -4.76% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 18.48% in intraday trading to $3.68- this Wednesday, Mar 31, hitting a weekly high. The stock’s 5-day price performance is -12.79%, and it has moved by -21.26% in 30 days. Despite these dips, the overall price performance for the year is 380%. The short interest in Asensus Surgical, Inc. (NYSE:ASXC) is 10.79 Million shares and it means that shorts have 0.33 day(s) to cover.
The consensus price target of analysts on Wall Street is $1.45, which implies a decline of -51.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.45 and $1.45 respectively. As a result, ASXC is trading at a discount of -51.67% off the target high and -51.67% off the low.
Asensus Surgical, Inc. (ASXC) projections and forecasts
Statistics show that Asensus Surgical, Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Asensus Surgical, Inc. (ASXC) shares have gone up +767.05% during the last six months, with a year-to-date growth rate less than the industry average at -58.73% against 22.4%. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 82.9% this quarter and then jump 71.4% in the quarter after that. In the rating firms’ projections, revenue will increase 138.4% compared to the previous financial year.
Revenue for the current quarter is expected to be $1.4 Million as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to $1.63 Million by the end of June 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarter totaled $600Million. In this case, analysts expect current quarter sales to grow by 133.3%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.6%. While earnings are projected to return 90.2% in 2021, the next five years will return 0% per annum.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Asensus Surgical, Inc. (NYSE:ASXC)’s Biggest Investors
Asensus Surgical, Inc. insiders own 1.79% of total outstanding shares while institutional holders control 9.95%, with the float percentage being 10.14%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 81 institutions own stock in it. As of Dec 30, 2020, the company held over 2.16 Million shares (or 0.93% of all shares), a total value of $1.35 Million in shares.
The next largest institutional holding, with 1.43 Million shares, is of Renaissance Technologies, LLC’s that is approximately 0.61% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $891.88 Thousand.
Also, the Mutual Funds coming in first place with the largest holdings of Asensus Surgical, Inc. (ASXC) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Dec 30, 2020 indicates that Vanguard Total Stock Market Index Fund owns about 1,496,006 shares. This amounts to just over 0.64 percent of the company’s overall shares, with a $935Thousand market value. The same data shows that the other fund manager holds slightly less at 577.95 Thousand, or about 0.25% of the stock, which is worth about $361.22 Thousand.